ATE534396T1 - Probiotische mikroorganismen zur verbesserung der muskulären funktion - Google Patents

Probiotische mikroorganismen zur verbesserung der muskulären funktion

Info

Publication number
ATE534396T1
ATE534396T1 AT03765107T AT03765107T ATE534396T1 AT E534396 T1 ATE534396 T1 AT E534396T1 AT 03765107 T AT03765107 T AT 03765107T AT 03765107 T AT03765107 T AT 03765107T AT E534396 T1 ATE534396 T1 AT E534396T1
Authority
AT
Austria
Prior art keywords
gut
probiotic microorganisms
muscular function
improve muscular
probiotics
Prior art date
Application number
AT03765107T
Other languages
English (en)
Inventor
Irene Corthesy-Theulaz
De Bercik Elena Verdu
Premysl Bercik
Stephen Collins
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29797269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE534396(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of ATE534396T1 publication Critical patent/ATE534396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03765107T 2002-07-23 2003-07-23 Probiotische mikroorganismen zur verbesserung der muskulären funktion ATE534396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02078064A EP1384483A1 (de) 2002-07-23 2002-07-23 Probiotische Mikroorganismen zur Behandlung von Colon Irritabile durch die Verbesserung der neuromuskulären Darmfunktion
PCT/EP2003/008076 WO2004009103A1 (en) 2002-07-23 2003-07-23 Probiotics for gut neuromuscular functions

Publications (1)

Publication Number Publication Date
ATE534396T1 true ATE534396T1 (de) 2011-12-15

Family

ID=29797269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03765107T ATE534396T1 (de) 2002-07-23 2003-07-23 Probiotische mikroorganismen zur verbesserung der muskulären funktion

Country Status (18)

Country Link
US (1) US8021656B2 (de)
EP (2) EP1384483A1 (de)
JP (1) JP2005538087A (de)
KR (1) KR20050025978A (de)
CN (1) CN100480370C (de)
AT (1) ATE534396T1 (de)
AU (1) AU2003250149B2 (de)
BR (1) BR0313185A (de)
CA (1) CA2493255A1 (de)
ES (1) ES2376664T3 (de)
IL (1) IL166442A0 (de)
MX (1) MXPA05000880A (de)
NO (1) NO20050896L (de)
NZ (1) NZ538335A (de)
PT (1) PT1531841E (de)
RU (2) RU2346036C2 (de)
WO (1) WO2004009103A1 (de)
ZA (1) ZA200501559B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004204751A1 (en) * 2003-01-09 2004-07-29 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
US7749509B2 (en) * 2003-08-29 2010-07-06 Cobb And Company, Llp Treatment of autism using probiotic composition
US8192733B2 (en) 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7731976B2 (en) * 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
CN101128129A (zh) * 2005-02-28 2008-02-20 纽崔西亚公司 具有益生菌的营养组合物
WO2007031129A1 (en) * 2005-07-20 2007-03-22 Unilever N.V. Edible product containing beneficial moulds and/or yeasts
US8246946B2 (en) * 2005-09-27 2012-08-21 Cobb & Associates Treatment of bipolar disorder utilizing anti-fungal compositions
CA2642431A1 (en) * 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
RU2448720C2 (ru) 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
US8815312B2 (en) * 2006-05-26 2014-08-26 Nestec S.A. Methods of use and nutritional compositions of Touchi Extract
US7951385B2 (en) * 2006-05-28 2011-05-31 Cipla Medpro Research And Development (Pty) Ltd. Probiotic strain and antimicrobial peptide derived therefrom
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
PL2209527T3 (pl) 2007-10-11 2013-03-29 Dupont Nutrition Biosci Aps Kompozycje farmaceutyczne zawierające probiotyki L.acidophilus i Bifidobacterium lactis do stosowania w leczeniu zaburzenia czynnościowego jelit
ES2395838T3 (es) * 2007-12-21 2013-02-15 Compagnie Gervais Danone Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium
AU2009246156A1 (en) * 2008-05-15 2009-11-19 Youdocs, Llc Methods and systems for improving human health using targeted probiotics
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
EP2216034A1 (de) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus-helveticus-CNCM I-4095 und Gewichtskontrolle
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
AU2010247469B2 (en) * 2009-05-11 2014-12-18 Société des Produits Nestlé S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
EP2251020A1 (de) * 2009-05-11 2010-11-17 Nestec S.A. Kurzzeitige Hochtemperaturbehandlung erzeugt mikrobielle Zubereitungen mit entzündungshemmenden Profilen
TR201807143T4 (tr) 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
JP5777640B2 (ja) * 2010-01-28 2015-09-09 アベ−バイオティックス・ソシエダッド・アノニマＡｂ−Ｂｉｏｔｉｃｓ Ｓ．Ａ． 腸炎症の処置における使用のためのプロバイオティクス組成物
DK2603086T3 (en) * 2010-08-10 2017-01-30 Chr Hansen As Nematocid composition containing bacillus subtilis and bacillus licheniformis
EP2455094A1 (de) * 2010-11-11 2012-05-23 Nestec S.A. Nicht replizierende probiotische Mikroorganismen als Schutz vor Magen-Darm-Infektionen bei Kindern
JP5681533B2 (ja) * 2011-03-14 2015-03-11 ビオフェルミン製薬株式会社 消化管痛の予防又は軽減剤
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
WO2013026033A2 (en) * 2011-08-18 2013-02-21 Dupont Nutrition Biosciences Aps Strains and methods useful for mycotoxins
EP2609813A1 (de) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 zur Entwicklung des enterischen Nervensystems
US20130251829A1 (en) 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
AU2013318513A1 (en) * 2012-09-20 2015-04-09 Prothera Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions
WO2014064488A1 (en) * 2012-10-25 2014-05-01 Compagnie Gervais Danone Streptococcus thermophilus strains for treating helicobacter pylori infection
WO2014096901A1 (en) * 2012-12-18 2014-06-26 Compagnie Gervais Danone Strain of bifidobacterium animalis ssp. animalis
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
EP3016527B1 (de) 2013-06-03 2018-07-25 Proprev AB Behandlung von adipositas, stoffwechselsyndrom, typ-2-diabetes, herz-kreislauf-erkrankungen, demenz, morbus alzheimer und entzündlicher darmerkrankung mit mindestens einem bakterienstamm aus prevotella
CA2920461C (en) * 2013-08-09 2023-01-03 Ab-Biotics, S.A. Probiotic for infantile excessive crying
CN103497988B (zh) * 2013-09-23 2014-10-29 广州康代生物科技有限公司 一种安全高效乳酸菌产品的发酵生产方法
EP3294308A4 (de) 2015-05-14 2019-03-06 University of Puerto Rico Verfahren zur wiederherstellung der biozönose von neugeborenen
RU2608871C1 (ru) * 2015-11-06 2017-01-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Вятский государственный университет" Штамм бактерий Lactobacillus paracasei 1, используемый для приготовления пробиотического препарата
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
CN105767507B (zh) * 2016-03-30 2020-12-01 遂平广源饲料科技有限公司 一种饲料用微生态制剂、无抗饲料及其制备方法
KR101765559B1 (ko) * 2016-09-27 2017-08-07 이대희 노루궁뎅이버섯을 포함하는 프로바이오틱스 조성물
KR20210141920A (ko) * 2018-12-21 2021-11-23 킴벌리-클라크 월드와이드, 인크. 요실금, 과민성 방광, 또는 월경 경련을 예방 또는 치료하기 위한 조성물 및 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562629B1 (en) * 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
BR0008920A (pt) * 1999-03-11 2001-12-18 Nestle Sa Cepas de lactobacillus capazes de prevenirdiarréia causada por bactéria patogênica erotaviroses
EP1034788A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Milchsäure Bakterienstämme zur Verhinderung von Diarrhöe
EP1034787A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen
CN1186440C (zh) * 1999-08-05 2005-01-26 雀巢制品公司 预防病原性细菌引起的腹泻的新双歧杆菌
BR0016973A (pt) * 2000-01-18 2002-10-15 Nestle Sa Composição alimentìcia de animais domésticos para tratamento de espécies de helicobacter em animais domésticos
ES2276793T3 (es) * 2000-03-24 2007-07-01 Societe Des Produits Nestle S.A. Empleo de la bacteria del acido lactico para la prevencion de la peritonitis.
JP2003535903A (ja) * 2000-06-19 2003-12-02 ミューコプロテック・プロプライエタリー・リミテッド プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
IT1320772B1 (it) * 2000-11-02 2003-12-10 Proge Farm Srl Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
ES2323450T3 (es) * 2001-02-19 2009-07-16 Societe Des Produits Nestle S.A. Producto consumible que contiene probioticos.
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria

Also Published As

Publication number Publication date
EP1531841A1 (de) 2005-05-25
EP1384483A1 (de) 2004-01-28
EP1531841B1 (de) 2011-11-23
NZ538335A (en) 2007-04-27
RU2490325C2 (ru) 2013-08-20
JP2005538087A (ja) 2005-12-15
WO2004009103A1 (en) 2004-01-29
ZA200501559B (en) 2006-05-31
IL166442A0 (en) 2006-01-15
BR0313185A (pt) 2005-06-21
US20070128178A1 (en) 2007-06-07
PT1531841E (pt) 2012-02-01
AU2003250149A1 (en) 2004-02-09
ES2376664T3 (es) 2012-03-15
RU2005104950A (ru) 2005-12-10
RU2008132327A (ru) 2010-02-10
CN100480370C (zh) 2009-04-22
NO20050896L (no) 2005-04-18
AU2003250149B2 (en) 2009-01-22
CA2493255A1 (en) 2004-01-29
RU2346036C2 (ru) 2009-02-10
MXPA05000880A (es) 2006-01-24
US8021656B2 (en) 2011-09-20
CN1678329A (zh) 2005-10-05
KR20050025978A (ko) 2005-03-14

Similar Documents

Publication Publication Date Title
ATE534396T1 (de) Probiotische mikroorganismen zur verbesserung der muskulären funktion
HUP0303728A2 (hu) Tápanyagkészítmény
BR0213189A (pt) Composição compreendendo uma cepa lactobacillus pentosus e usos da mesma
ATE439138T1 (de) Probiotika zur primären prävention atopischer erkrankungen
NZ599302A (en) Preventing diseases in infants delivered via caesarean section
IL144184A0 (en) Use of lactobacillus salivarius
HUP0200205A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
EP1498039A4 (de) Lebende zellpräparate, die milchsäurebakterium als wirkstoff enthalten, sowie milchsäurebakteriumhaltige nahrungsmittel
ATE354964T1 (de) Probiotische zusammensetzung mit mindestens zwei milchsäurebakterienstämmen, die zur kolonisierung des magen-darm-trakts fähig sind und in kombination damit die eigenschaften, im darm zu überleben, an den darm zu binden, gegen infektion zu schützen und ballaststoffe zu fermentieren, aufweisen
DE60000825D1 (de) Pharmazeutische zusammensetzungen für medizinische und veterinäre verwendung zur verbesserung der darmflora bei dyspeptischem syndrom und diarrhoeen auf dem veterinärsektor
DK1643861T3 (da) Fiber- og kalorierig flydende næringssammensætning til tarmsundhed hos ældre patienter
MXPA04005346A (es) Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.
EE200300220A (et) Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod
PL1853308T3 (pl) Podawany drogą pokarmową preparat farmaceutyczny dla ryb, jego sposób wytwarzania oraz jego zastosowanie
AU5069500A (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
ES2155783A1 (es) Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
RU2002129937A (ru) Штамм бактерий bacillus subtilis, используемый для получения пробиотического препарата, предназначенного для профилактики и лечения желудочно-кишечных заболеваний сельскохозяйственных животных, птицы и рыбы
ES2155782A1 (es) Utilizacion de bacterias acidolacticas pra preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos.
MD20010076A (ro) Preparat microbian sanogenic pentru asanarea tubului digestiv şi tratamentul disbacteriozei